About Randox
Randox is a company based in Crumlin (United Kingdom) founded in 1982 by Peter Fitzgerald. Randox has completed 1 acquisition, including Cellix. Randox operates in a competitive market with competitors including Roche, EKF, SonoSite, Cordant Health Solutions and NVision Imaging Technologies, among others.
- Headquarter Crumlin, United Kingdom
- Founders Peter Fitzgerald
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Randox Holdings Limited
- Date of Incorporation 28 Sep, 2012
- Jurisdiction CRUMLIN, ANTRIM
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$67.94 M (USD), Debt – Conventional
Jul 10, 2025
-
Investors
European Union
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Randox
Investors in Randox
Randox has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and HSBC UK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
HSBC UK is engaged in providing personal and business banking services.
|
Locked | Locked | Locked |
Investor details for Randox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Randox
Randox has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cellix.
Investment portfolio details for Randox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microfluidics, biochips, and high-throughput gene-editing technologies are manufactured.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Randox
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Randox
Detailed financials for Randox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Randox Comparisons
Peer comparison for Randox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Randox
Randox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, EKF, SonoSite, Cordant Health Solutions and NVision Imaging Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Point-of-care and laboratory blood analyzers are developed by EKF.
|
|
| Locked | Locked | Locked |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| Locked | Locked | Locked |
Drug testing services are offered for clinical trials and workplaces.
|
|
| Locked | Locked | Locked |
Medical imaging is provided through quantum technologies.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for immunoassay tests are provided to clinicians.
|
Detailed competitors of Randox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Randox
Complete news archive for Randox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Randox
Randox was founded in 1982 and raised its 1st funding round 31 years after it was founded.
Randox is headquartered in Crumlin, United Kingdom. It is registered at Crumlin, Northern Ireland, United Kingdom.
Randox Laboratories was founded in 1982 in Crumlin, United Kingdom, and operates in the clinical diagnostics sector. A range of semi-automated and fully automated analyzers in the Rx series is provided for clinical chemistry. Reagents and biochip-based immunoassays are offered across therapeutic areas such as immunology, oncology, cardiovascular, and infectious diseases. Molecular diagnostic services are also supplied to support healthcare applications.
Randox has made 1 acquisition, including Cellix.
Randox has 2 investors. Key investors include European Union, and HSBC UK.